CAS 1013101-36-4 – 2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)…

CAS No.

1013101-36-4

MDL No.

N/A

C₂₂H₂₇N₅O₄

425.50

InChI Key

XDLYKKIQACFMJG-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

On Request

Custom synthesis and bulk supply options are available upon request.

Product Information

PF-04691502 is a PI3K/mTOR kinase inhibitor that targets the PI3K and mTOR components of the PI3K/mTOR signaling pathway, exhibiting potential antineoplastic activity.

CAS No.	1013101-36-4
Product Name	2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one

Heavy Atom Count	31	Rotatable Bond Count	6
Atom Stereo Count	0	Bond Stereo Count	0
HBA	9	HBD	2
TPSA	125.380 Å²	Charge	0
Exact Mass	425.20630	Complexity	1121.43
pKa	7.130	XLogP	2.245

2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one

Pricing & Availability

Product Information

Properties

Documentation

2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one

Pricing & Availability

Product Information

Properties

Related Articles

Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in Kras(G12D-LSL) mice.

Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor Activity.

PF-04691502, a potent and selective oral inhibitor of PI3K and mTOR kinases with antitumor activity.

Documentation

Similar Products

Voxtalisib